P2X7 purinergic receptor: A potential target in heart diseases (Review).

Bin Dayel, Anfal F; Alonazi, Asma S; Alshammari, Tahani K; Alrasheed, Nouf M

Bin Dayel, Anfal F; Alonazi, Asma S; Alshammari, Tahani K; Alrasheed, Nouf M.

Afiliación

Bin Dayel AF; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, 12371 Riyadh, Kingdom of Saudi Arabia.
Alonazi AS; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, 12371 Riyadh, Kingdom of Saudi Arabia.
Alshammari TK; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, 12371 Riyadh, Kingdom of Saudi Arabia.
Alrasheed NM; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, 12371 Riyadh, Kingdom of Saudi Arabia.

Mol Med Rep ; 27(3)2023 Mar.

Article en En | MEDLINE | ID: mdl-36799169

Asunto(s)

COVID-19; Infarto del Miocardio; Miocarditis; Humanos; Adenosina Trifosfato/farmacología; COVID-19/genética; Infarto del Miocardio/genética; Miocarditis/genética; Antagonistas del Receptor Purinérgico P2X/farmacología; Antagonistas del Receptor Purinérgico P2X/uso terapéutico; Receptores Purinérgicos P2X7/genética

Palabras clave

P2X7 purinergic receptor; cardiomyopathy; myocardial infarction; myocardial injury induced by coronavirus; myocarditis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Infarto del Miocardio / Miocarditis Límite: Humans Idioma: En Revista: Mol Med Rep Año: 2023 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google